ArticleRespiratory medicine case reports2026
Pulmonary embolism after treatment for massive hemoptysis: a therapeutic dilemma.
Article in Respiratory medicine case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Massive hemoptysis is a life-threatening condition requiring prompt hemostatic intervention. After hemostatic treatment, thromboembolic complications may pose a dilemma when anticoagulation is necessary but carries a risk of rebleeding. A 72-year-old man with chronic obstructive pulmonary disease was admitted for recurrent hemoptysis. Bronchial angiography revealed a markedly dilated right bronchial artery with intrapulmonary shunting. Because of massive hemoptysis and respiratory failure, emergency bronchial artery embolization was performed, followed by right middle lobectomy with corresponding bronchial artery ligation to reduce rebleeding risk. After surgery, persistent bleeding from segmental bronchi was controlled by endobronchial Watanabe spigot. Pulmonary embolism was subsequently detected by contrast-enhanced computed tomography. A second bronchial angiography confirmed complete hemostasis before anticoagulation. Heparin infusion was initiated, followed by a switch to edoxaban. He recovered without recurrent hemoptysis. This case highlights the challenge of balancing hemostasis and anticoagulation when pulmonary embolism develops after stepwise multimodal hemostatic therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.